发明名称 Process for preparing a medicament
摘要 The present invention provides a process for preparing a particulate medicament that has greater homogeneity and a lower adhesion between the particles of the active ingredient and the carrier. The process comprises the steps of: (a) combining a pharmaceutically active ingredient in the form of an agglomerate of primary particles having an agglomerate particle size such that the agglomerate is capable of passing through a sieve having a mesh of 50-3000 .mu.m with a pharmaceutically acceptable particulate carrier, and (b) mixing the resultant material in a mixer to break up the agglomerate into primary particles dispersed in the pharmaceutically acceptable particulate carrier such that 90% or more of the pharmaceutically active ingredient exists as primary particles having a particle size of 50 .mu.m or less.
申请公布号 US9616024(B2) 申请公布日期 2017.04.11
申请号 US201615137671 申请日期 2016.04.25
申请人 Norton Healthcare Ltd. 发明人 Zeng Xian-Ming;Tee Seah Kee
分类号 A61K9/14;A61M15/00;A61K31/58;A61K9/00;A61K31/167;A61K31/137;A61K9/16;A61K31/56 主分类号 A61K9/14
代理机构 Morgan, Lewis & Bockius, LLP 代理人 Morgan, Lewis & Bockius, LLP
主权项 1. An inhalable medicament prepared by a process comprising the steps of: (a) forming a plurality of loose agglomerates of a pharmaceutically active ingredient by passing the pharmaceutically active ingredient through a sieve having a mesh of 50-3000 μm, wherein the loose agglomerates are not spheronized; (b) combining the plurality of loose agglomerates obtained from step (a) with a pharmaceutically acceptable particulate carrier; and (c) mixing the resultant material from step (b) in a mixer outside of an inhaler to break up the loose agglomerates into primary particles of the pharmaceutically active ingredient and to disperse the primary particles in the pharmaceutically acceptable particulate carrier such that 90% or more of the pharmaceutically active ingredient has a particle size of 50 μm or less to provide the inhalable medicament.
地址 London GB